BVF Inc’s Chinook Therapeutics KDNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-1,800,000
Closed -$29.4M – 84
2021
Q4
$29.4M Buy
+1,800,000
New +$25.6M 1.07% 27
2019
Q4
– Sell
-202,000
Closed -$1.07M – 62
2019
Q3
$1.07M Buy
+202,000
New +$1.34M 0.11% 55
2018
Q4
– Sell
-57,555
Closed -$2.12M – 57
2018
Q3
$2.12M Sell
57,555
-1,638
-3% -$52.6K 0.19% 52
2018
Q2
$2.07M Sell
59,193
-102,114
-63% -$3.92M 0.2% 48
2018
Q1
$7.5M Buy
+161,307
New +$5.9M 0.76% 30
2017
Q4
– Sell
-36,953
Closed -$1.97M – 45
2017
Q3
$1.97M Sell
36,953
-23,047
-38% -$1.37M 0.25% 34
2017
Q2
$3.42M Buy
+60,000
New +$3.01M 0.53% 28
2017
Q1
– Sell
-149,177
Closed -$8.5M – 32
2016
Q4
$8.5M Buy
149,177
+48,946
+49% +$2.96M 1.71% 18
2016
Q3
$6.23M Sell
100,231
-2,490
-2% -$176K 1.17% 22
2016
Q2
$5.81M Buy
+102,721
New +$6.24M 1.24% 22

Other funds holding KDNY

BVF Inc's KDNY Position: Q1 2022 in Review

BVF Inc sold out of Chinook Therapeutics (KDNY) in Q1 2022, closing a stake of 1,800,000 shares — an estimated $29.4M sold.

BVF Inc first reported a position in KDNY in Q2 2016 and held it in 10 quarters. The position peaked at $29.4M in Q4 2021. 105 funds tracked by Wall St. Rank hold KDNY as of Q1 2022.

  • BVF Inc reported no remaining Chinook Therapeutics position as of Q1 2022 after selling out during the quarter.
  • BVF Inc sold 1,800,000 Chinook Therapeutics shares in Q1 2022, an estimated $29.4M.
  • BVF Inc first reported a position in Chinook Therapeutics in Q2 2016 and held it in 10 quarters.
  • BVF Inc's Chinook Therapeutics position peaked at $29.4M in Q4 2021.
  • 105 funds tracked by Wall St. Rank held Chinook Therapeutics as of Q1 2022.

Based on BVF Inc's 13F filing for Q1 2022, filed 16 May 2022.